The enrichment of KRAS signaling upon VHL restoration is probably related to the paradoxical function of HIF2α to constrain KRAS-AKT signaling in non-small cell lung cancer driven by KrasG12D [70]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.